The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Traditional use and safety of herbal medicines1
Open accessAbstract
In the European Union, traditional herbal medicines that are regarded as “acceptably safe, albeit not having a recognized level of efficacy” fit into a special category of drugs (“traditional herbal medicine products”) for which requirements of non-clinical and clinical studies are less rigorous. A regulation proposal published by the Brazilian National Health Surveillance (Anvisa) defines a similar drug category (“traditional phytotherapeutic products”) for registration purposes. Regarding herbal medicines, both agencies seem to be lenient regarding proof of efficacy, and consider long-standing folk use as evidence of safety and a waiver of a thorough toxicological evaluation. Nonetheless, several herbal products and constituents with a long history of folk usage are suspected carcinogenic and/or hepatotoxic. Herbal products have also been shown to inhibit and/or induce drug-metabolizing enzymes. Since herbal medicines are often used in conjunction with conventional drugs, kinetic and clinical interactions are a cause for concern. A demonstration of the safety of herbal medicines for registration purposes should include at least in vitro and in vivo genotoxicity assays, long-term rodent carcinogenicity tests (for drugs intended to be continuously used for > 3 months or intermittently for > 6 months), reproductive and developmental toxicity studies (for drugs used by women of childbearing age), and investigation of the effects on drug-metabolizing enzymes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Artichoke leaf extract for treating hypercholesterolaemia
Wider, B., Pittler, M. H., Coon, J. T., & Ernst, E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003335.pub3 · Cited by 123
RetractedEvidence based medicine: what it is and what it isn't
Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., & Richardson, W. S. (1996) · BMJ · doi:10.1136/bmj.312.7023.71 · Cited by 15,769
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Yeh, M.-L. (2014) · Journal of Nursing Research · doi:10.1097/jnr.0000000000000065 · Cited by 3,829
Shepard, T. H. (1981) · Teratology · doi:10.1002/tera.1420230118 · Cited by 1,296
Shang, A., Huwiler-Müntener, K., Nartey, L., Jüni, P., Dörig, S., Sterne, J. A., Pewsner, D., & Egger, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67177-2 · Cited by 839
Grapefruit juice–drug interactions
Bailey, D. G., Malcolm, J., Arnold, O., & David Spence, J. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00764.x · Cited by 740
Toxicity of Pyrrolizidine Alkaloids
MATTOCKS, A. R. (1968) · Nature · doi:10.1038/217723a0 · Cited by 475
Origin and Uses of Primum Non Nocere—Above All, Do No Harm!
Smith, C. M. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004273680 · Cited by 408
Drug Interactions with Grapefruit Juice
Ameer, B., & Weintraub, R. A. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733020-00003 · Cited by 348
Cited by
Seca, A., & Pinto, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010263 · Cited by 686
Regulatory landscape of dietary supplements and herbal medicines from a global perspective
Thakkar, S., Anklam, E., Xu, A., Ulberth, F., Li, J., Li, B., Hugas, M., Sarma, N., Crerar, S., Swift, S., et al. (2020) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2020.104647 · Cited by 283
Liu, Y., Wang, W., Sun, M., Ma, B., Pang, L., Du, Y., Dong, X., Yin, X., & Ni, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01467 · Cited by 49
Metadata
- Authors
- Moreira, D. D. L., Teixeira, S. S., Monteiro, M. H. D., De-Oliveira, A. C. A. X., & Paumgartten, F. J. R.
- Venue
- Revista Brasileira de Farmacognosia
- Published
- 2014-03
- Volume
- 24
- Issue
- 2
- Pages
- 248-257
- ISSN
- 0102-695X (ISSN-L)
- OpenAlex
- W1581501992
- Cited by
- 266
- References
- 78
- FWCI
- 10.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Traditional use and safety of herbal medicines1. https://app.cochat.ai/papers/10.1016/j.bjp.2014.03.006
- The paper
- Moreira, D. D. L., Teixeira, S. S., Monteiro, M. H. D., De-Oliveira, A. C. A. X., & Paumgartten, F. J. R. (2014). Traditional use and safety of herbal medicines1. Revista Brasileira de Farmacognosia. https://doi.org/10.1016/j.bjp.2014.03.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.